five

Available datapackage for study 'A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer'

收藏
DataCite Commons2026-04-05 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/dataPackages/PR00012120.0
下载链接
链接失效反馈
官方服务:
资源简介:
The primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.
提供机构:
Vivli
创建时间:
2026-04-05
二维码
社区交流群
二维码
科研交流群
商业服务